🇺🇸 FDA
Pipeline program

alglucosidase alfa

AGLU07710

Approved mab completed

Quick answer

alglucosidase alfa for Pompe Disease is a Approved program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Pompe Disease
Phase
Approved
Modality
mab
Status
completed

Clinical trials